Why the study?
The contribution of short-term glycemic variability (within-day and between-day glycemic oscillations) to diabetic complications remains an enigma.
Does short-term glycemic variability contribute to microvascular and macrovascular complications in patients with diabetes?
Population
Patients with diabetes
Design
Review
Authors
Loading...
GV metrics via CGM extend beyond HbA1c; leaves open their CV prognostic role pending trials.
Does short-term glycemic variability contribute to microvascular and macrovascular complications in patients with diabetes?
Short-term glycemic variability is an emerging metric that may be associated with microvascular and macrovascular complications in patients with diabetes.
Psoma et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: